Espada, Khian A.
HRN: 23-38-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2023
CEFTRIAXONE 1G (VIAL)
07/19/2023
07/25/2023
IV
2g
Q24H
Acute Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes